.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Global Oncology News
AML: Evolving Perspectives on Testing, Therapies, & Transplantation
Join us to learn about the impact of MRD in cancer

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Updates in the Management of Hairy Cell Leukemia

Introduction and Epidemiology of Hairy Cell Leukemia

June 30th 2020

Molecular Genetic Changes for Hairy Cell Leukemia

June 30th 2020

Signs and Tests for Diagnosis and Prognosis of HCL

June 30th 2020

Differential Diagnosis and Molecular Tests in Identifying HCL

June 30th 2020

Determining When to Treat and First-Line Therapy for HCL

June 30th 2020

Combination First-line Therapy in Hairy Cell Leukemia

June 30th 2020

When to Not Use Combination and the Need for Bone Marrow Biopsy in HCL

June 30th 2020

Historical Treatment for Relapsed/Refractory HCL

June 30th 2020

Landscape Change in the Treatment of Relapsed/Refractory HCL

June 30th 2020

The Role of CD22-targeted Immunotoxins in HCL

June 30th 2020